PFE Competitors & Alternatives
Industry Overview
Pfizer Inc. operates in the Drug Manufacturers - General industry within the Healthcare sector.
Competitor Comparison
| Company | Price | Market Cap | P/E Ratio | Div Yield | 1Y Return | Rating |
|---|---|---|---|---|---|---|
| PFE Pfizer Inc. | $27.06 | $146.75B | 14.9 | 0.07% | +1.84% | |
| AMGN Amgen Inc. | $376.12 | $170.91B | 24.4 | 0.03% | +18.53% | |
| BMY Bristol-Myers Squibb Company | $60.87 | $104.23B | 17.3 | 0.05% | -11.14% | |
| BSX Boston Scientific Corporation | $74.65 | $135.98B | 48.7 | 0.00% | — | |
| DHR Danaher Corporation | $207.63 | $166.50B | 47.1 | 0.01% | -6.07% | |
| GILD Gilead Sciences, Inc. | $143.72 | $152.89B | 18.9 | 0.03% | +31.06% | |
| GSK GSK plc | $58.49 | $99.39B | 13.4 | 0.03% | — | |
| MRK Merck & Co., Inc. | $119.46 | $248.84B | 13.0 | 0.03% | -2.09% | |
| NVO Novo Nordisk A/S | $37.44 | $223.45B | 12.8 | 0.04% | — | |
| SNY Sanofi | $48.14 | $119.04B | 11.2 | 0.05% | — | |
| SYK Stryker Corporation | $383.33 | $134.97B | 45.9 | 0.01% | -6.89% |
Compare PFE to Other Stocks
Use our stock comparison tool to analyze PFE against any other stocks side-by-side.
Compare Stocks
